{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:22Z","timestamp":1787032882600,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,27]]},"DOI":"10.7759\/cureus.27330","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T07:41:52Z","timestamp":1658907712000},"source":"Crossref","is-referenced-by-count":50,"title":["A Review of the Etiology and Epidemiology of Bladder Cancer: All You Need To Know"],"prefix":"10.7759","author":[{"given":"Sattam A","family":"Halaseh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahed","family":"Halaseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaman","family":"Alali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohannad E","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad J","family":"Alharayzah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-249. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00038.2003","article-title":"Urinary bladder contraction and relaxation: physiology and pathophysiology","volume":"84","author":"Andersson KE","year":"2004","unstructured":"Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004, 84:935-986. 10.1152\/physrev.00038.2003","journal-title":"Physiol Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19199-z","article-title":"The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection","volume":"8","author":"Wong MC","year":"2018","unstructured":"Wong MC, Fung FD, Leung C, Cheung WW, Goggins WB, Ng CF. The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci Rep. 2018, 8:1129. 10.1038\/s41598-018-19199-z","journal-title":"Sci Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.05976.x","article-title":"A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic","volume":"97","author":"Edwards TJ","year":"2006","unstructured":"Edwards TJ, Dickinson AJ, Natale S, Gosling J, McGrath JS. A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic. BJU Int. 2006, 97:301-305. 10.1111\/j.1464-410X.2006.05976.x","journal-title":"BJU Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.10.024","article-title":"Economic burden of bladder cancer across the European Union","volume":"69","author":"Leal J","year":"2016","unstructured":"Leal J, Luengo-Fernandez R, Sullivan R, Witjes JA. Economic burden of bladder cancer across the European Union. Eur Urol. 2016, 69:438-447. 10.1016\/j.eururo.2015.10.024","journal-title":"Eur Urol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1016\/S0889-8588(18)30360-5","article-title":"Epidemiology of bladder cancer","volume":"6","author":"Silverman DT","year":"1992","unstructured":"Silverman DT, Hartge P, Morrison AS, Devesa SS. Epidemiology of bladder cancer. Hematol Oncol Clin North Am. 1992, 6:1-30.","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"Babjuk M","year":"2013","unstructured":"Babjuk M, Burger M, Zigeuner R, et al.. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013, 64:639-653. 10.1016\/j.eururo.2013.06.003","journal-title":"Eur Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni S","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017, 71:96-108. 10.1016\/j.eururo.2016.06.010","journal-title":"Eur Urol"},{"key":"ref9","unstructured":"Cancer survival in England - adults diagnosed. (2019). Accessed. July 1, 2022: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/datasets\/cancersurvival...."},{"key":"ref10","unstructured":"Recent Trends in SEER Age-Adjusted Incidence Rates, 2000-2019. (2019). Accessed. July 1, 2022: http:\/\/SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, Na...."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu223","article-title":"Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Bellmunt J","year":"2014","unstructured":"Bellmunt J, Orsola A, Leow JJ, Wiegel T, De Santis M, Horwich A. Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014, 25:40-48. 10.1093\/annonc\/mdu223","journal-title":"Ann Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.235","article-title":"The current classification of urothelial neoplasms","volume":"22","author":"Grignon DJ","year":"2009","unstructured":"Grignon DJ. The current classification of urothelial neoplasms. Mod Pathol. 2009, 22:S60-S69. 10.1038\/modpathol.2008.235","journal-title":"Mod Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpsur.2019.07.003","article-title":"Bladder cancer","volume":"37","author":"Mushtaq J","year":"2019","unstructured":"Mushtaq J, Thurairaja R, Nair R. Bladder cancer. Surgery. 2019, 37:529-537. 10.1016\/j.mpsur.2019.07.003","journal-title":"Surgery"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2014.10.001","article-title":"Global and regional patterns of tobacco smoking and tobacco control policies","volume":"1","author":"Islami F","year":"2015","unstructured":"Islami F, Stoklosa M, Drope J, Jemal A. Global and regional patterns of tobacco smoking and tobacco control policies. Eur Urol Focus. 2015, 1:3-16. 10.1016\/j.euf.2014.10.001","journal-title":"Eur Urol Focus"},{"key":"ref15","article-title":"How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General","author":"Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US)","year":"2010","unstructured":"Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Centers for Disease Control and Prevention (US), Atlanta (GA); 2010."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.06.042","article-title":"The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks","volume":"70","author":"Cumberbatch MG","year":"2016","unstructured":"Cumberbatch MG, Rota M, Catto JW, La Vecchia C. The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol. 2016, 70:458-466. 10.1016\/j.eururo.2015.06.042","journal-title":"Eur Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.179","article-title":"Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study","volume":"117","author":"Koshiaris C","year":"2017","unstructured":"Koshiaris C, Aveyard P, Oke J, Ryan R, Szatkowski L, Stevens R, Farley A. Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study. Br J Cancer. 2017, 117:1224-1232. 10.1038\/bjc.2017.179","journal-title":"Br J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13878","article-title":"Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database","volume":"120","author":"Chappidi MR","year":"2017","unstructured":"Chappidi MR, Kates M, Tosoian JJ, Johnson MH, Hahn NM, Bivalacqua TJ, Pierorazio PM. Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database. BJU Int. 2017, 120:377-386. 10.1111\/bju.13878","journal-title":"BJU Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23856","article-title":"The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses","volume":"124","author":"Hemelt M","year":"2009","unstructured":"Hemelt M, Yamamoto H, Cheng KK, Zeegers MP. The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses. Int J Cancer. 2009, 124:412-419. 10.1002\/ijc.23856","journal-title":"Int J Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.10.006","article-title":"Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study","volume":"219","author":"Karagas MR","year":"2005","unstructured":"Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT. Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett. 2005, 219:63-69. 10.1016\/j.canlet.2004.10.006","journal-title":"Cancer Lett"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28022","article-title":"Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study","volume":"133","author":"Daugherty SE","year":"2013","unstructured":"Daugherty SE, Lacey JV Jr, Pfeiffer RM, Park Y, Hoover RN, Silverman DT. Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer. 2013, 133:462-472. 10.1002\/ijc.28022","journal-title":"Int J Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9020020","article-title":"Androgen receptor signaling in bladder cancer","volume":"9","author":"Li P","year":"2017","unstructured":"Li P, Chen J, Miyamoto H. Androgen receptor signaling in bladder cancer. Cancers (Basel). 2017, 9:10.3390\/cancers9020020","journal-title":"Cancers (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2217\/pme.11.15","article-title":"Genetic susceptibility to bladder cancer risk and outcome","volume":"8","author":"Gu J","year":"2011","unstructured":"Gu J, Wu X. Genetic susceptibility to bladder cancer risk and outcome. Per Med. 2011, 8:365-374. 10.2217\/pme.11.15","journal-title":"Per Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67137-1","article-title":"NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses","volume":"366","author":"Garc\u00eda-Closas M","year":"2005","unstructured":"Garc\u00eda-Closas M, Malats N, Silverman D, et al.. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet. 2005, 366:649-659. 10.1016\/S0140-6736(05)67137-1","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/03008880802283755","article-title":"Hereditary bladder cancer","author":"Kiemeney LA","year":"2008","unstructured":"Kiemeney LA. Hereditary bladder cancer. Scand J Urol Nephrol Suppl. 2008, 110-115. 10.1080\/03008880802283755","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2010.076992","article-title":"Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers","volume":"47","author":"van der Post RS","year":"2010","unstructured":"van der Post RS, Kiemeney LA, Ligtenberg MJ, et al.. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. J Med Genet. 2010, 47:464-470. 10.1136\/jmg.2010.076992","journal-title":"J Med Genet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1897-4287-8-6","article-title":"Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients","volume":"8","author":"Riegert-Johnson DL","year":"2010","unstructured":"Riegert-Johnson DL, Gleeson FC, Roberts M, Tholen K, Youngborg L, Bullock M, Boardman LA. Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract. 2010, 8:6. 10.1186\/1897-4287-8-6","journal-title":"Hered Cancer Clin Pract"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel RL","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020, 70:7-30. 10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.3209","article-title":"Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysis","volume":"1","author":"Cumberbatch MG","year":"2015","unstructured":"Cumberbatch MG, Cox A, Teare D, Catto JW. Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysis. JAMA Oncol. 2015, 1:1282-1290. 10.1001\/jamaoncol.2015.3209","journal-title":"JAMA Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger M","year":"2013","unstructured":"Burger M, Catto JW, Dalbagni G, et al.. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013, 63:234-241. 10.1016\/j.eururo.2012.07.033","journal-title":"Eur Urol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.601","article-title":"Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study","volume":"112","author":"Vermeulen SH","year":"2015","unstructured":"Vermeulen SH, Hanum N, Grotenhuis AJ, et al.. Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer. 2015, 112:594-600. 10.1038\/bjc.2014.601","journal-title":"Br J Cancer"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603510","article-title":"Gonorrhoea and male bladder cancer in a prospective study","volume":"96","author":"Michaud DS","year":"2007","unstructured":"Michaud DS, Platz EA, Giovannucci E. Gonorrhoea and male bladder cancer in a prospective study. Br J Cancer. 2007, 96:169-171. 10.1038\/sj.bjc.6603510","journal-title":"Br J Cancer"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-4997-y","article-title":"Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics","volume":"37","author":"Bernardo C","year":"2016","unstructured":"Bernardo C, Cunha MC, Santos JH, et al.. Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics. Tumour Biol. 2016, 37:11279-11287. 10.1007\/s13277-016-4997-y","journal-title":"Tumour Biol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.1.97","article-title":"Relationship between schistosomiasis and bladder cancer","volume":"12","author":"Mostafa MH","year":"1999","unstructured":"Mostafa MH, Sheweita SA, O'Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev. 1999, 12:97-111. 10.1128\/CMR.12.1.97","journal-title":"Clin Microbiol Rev"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25592","article-title":"Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"128","author":"Ros MM","year":"2011","unstructured":"Ros MM, Bas Bueno-de-Mesquita HB, B\u00fcchner FL, et al.. Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2011, 128:2695-2708. 10.1002\/ijc.25592","journal-title":"Int J Cancer"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001736","article-title":"Chronic indwelling urinary catheter increase the risk of bladder cancer, even in patients without spinal cord injury","volume":"94","author":"Ho CH","year":"2015","unstructured":"Ho CH, Sung KC, Lim SW, Liao CH, Liang FW, Wang JJ, Wu CC. Chronic indwelling urinary catheter increase the risk of bladder cancer, even in patients without spinal cord injury. Medicine (Baltimore). 2015, 94:e1736. 10.1097\/MD.0000000000001736","journal-title":"Medicine (Baltimore)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1354","article-title":"Pioglitazone and bladder cancer risk: a systematic review and meta-analysis","volume":"7","author":"Tang H","year":"2018","unstructured":"Tang H, Shi W, Fu S, Wang T, Zhai S, Song Y, Han J. Pioglitazone and bladder cancer risk: a systematic review and meta-analysis. Cancer Med. 2018, 7:1070-1080. 10.1002\/cam4.1354","journal-title":"Cancer Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.7.524","article-title":"Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma","volume":"87","author":"Travis LB","year":"1995","unstructured":"Travis LB, Curtis RE, Glimelius B, et al.. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst. 1995, 87:524-530. 10.1093\/jnci\/87.7.524","journal-title":"J Natl Cancer Inst"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950801)76:3<442::aid-cncr2820760315>3.0.co;2-l","article-title":"Second primary cancer after treatment for cervical cancer. An international cancer registries study","volume":"76","author":"Kleinerman RA","year":"1995","unstructured":"Kleinerman RA, Boice JD Jr, Storm HH, et al.. Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer. 1995, 76:442-452. 10.1002\/1097-0142(19950801)76:3&lt;442::aid-cncr2820760315&gt;3.0.co;2-l","journal-title":"Cancer"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000163459.57305.a1","article-title":"Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer","volume":"174","author":"Chrouser K","year":"2005","unstructured":"Chrouser K, Leibovich B, Bergstralh E, Zincke H, Blute M. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol. 2005, 174:107-110. 10.1097\/01.ju.0000163459.57305.a1","journal-title":"J Urol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19531-7","article-title":"Estimating the impact of body mass index on bladder cancer risk: stratification by smoking status","volume":"8","author":"Choi JB","year":"2018","unstructured":"Choi JB, Lee EJ, Han KD, Hong SH, Ha US. Estimating the impact of body mass index on bladder cancer risk: stratification by smoking status. Sci Rep. 2018, 8:947. 10.1038\/s41598-018-19531-7","journal-title":"Sci Rep"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay J","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, et al.. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015, 136:E359-E386. 10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(02)00849-5","article-title":"Overweight, obesity, and cancer risk","volume":"3","author":"Bianchini F","year":"2002","unstructured":"Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol. 2002, 3:565-574. 10.1016\/s1470-2045(02)00849-5","journal-title":"Lancet Oncol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000036380.10325.2a","article-title":"Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk","volume":"169","author":"Zhao H","year":"2003","unstructured":"Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, Wu X. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003, 169:714-717. 10.1097\/01.ju.0000036380.10325.2a","journal-title":"J Urol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-016-0138-6","article-title":"Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses","volume":"31","author":"Al-Zalabani AH","year":"2016","unstructured":"Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP. Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol. 2016, 31:811-851. 10.1007\/s10654-016-0138-6","journal-title":"Eur J Epidemiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23116","article-title":"Passive smoking and lung cancer in Japanese non-smoking women: a prospective study","volume":"122","author":"Kurahashi N","year":"2008","unstructured":"Kurahashi N, Inoue M, Liu Y, Iwasaki M, Sasazuki S, Sobue T, Tsugane S. Passive smoking and lung cancer in Japanese non-smoking women: a prospective study. Int J Cancer. 2008, 122:653-657. 10.1002\/ijc.23116","journal-title":"Int J Cancer"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.77","article-title":"The association between physical activity and bladder cancer: systematic review and meta-analysis","volume":"110","author":"Keimling M","year":"2014","unstructured":"Keimling M, Behrens G, Schmid D, Jochem C, Leitzmann MF. The association between physical activity and bladder cancer: systematic review and meta-analysis. Br J Cancer. 2014, 110:1862-1870. 10.1038\/bjc.2014.77","journal-title":"Br J Cancer"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2147\/RRTM.S44274","article-title":"Prevention and control of schistosomiasis: a current perspective","volume":"2014","author":"Inobaya MT","year":"2014","unstructured":"Inobaya MT, Olveda RM, Chau TN, Olveda DU, Ross AG. Prevention and control of schistosomiasis: a current perspective. Res Rep Trop Med. 2014, 2014:65-75. 10.2147\/RRTM.S44274","journal-title":"Res Rep Trop Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.5812\/ijcm.9430","article-title":"Halting Schistosoma haematobium - associated bladder cancer","volume":"10","author":"Botelho MC","year":"2017","unstructured":"Botelho MC, Alves H, Richter J. Halting Schistosoma haematobium - associated bladder cancer. Int J Cancer Manag. 2017, 10:e9430. 10.5812\/ijcm.9430","journal-title":"Int J Cancer Manag"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.4700030204","article-title":"Periodic urine cytology surveillance of bladder tumor incidence in dyestuff workers","volume":"3","author":"Yamaguchi N","year":"1982","unstructured":"Yamaguchi N, Tazaki H, Okubo T, Toyama T. Periodic urine cytology surveillance of bladder tumor incidence in dyestuff workers. Am J Ind Med. 1982, 3:139-148. 10.1002\/ajim.4700030204","journal-title":"Am J Ind Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1993.tb16292.x","article-title":"Three-year follow-up of bladder tumours found on screening","volume":"72","author":"Whelan P","year":"1993","unstructured":"Whelan P, Britton JP, Dowell AC. Three-year follow-up of bladder tumours found on screening. Br J Urol. 1993, 72:893-896. 10.1111\/j.1464-410x.1993.tb16292.x","journal-title":"Br J Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/105534-a-review-of-the-etiology-and-epidemiology-of-bladder-cancer-all-you-need-to-know","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:35:52Z","timestamp":1707489352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/105534-a-review-of-the-etiology-and-epidemiology-of-bladder-cancer-all-you-need-to-know"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.27330","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,27]]}}}